Hyderabad: Global pharma heavyweights Eli Lilly and Novo Nordisk are racing to lock in market leadership in India’s blooming ...

U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

As Novo Nordisk’s FDA-approved Wegovy pill sets up a high-stakes comeback, should NVO be back on investors’ radar now?

As GLP-1 weight-loss drugs become more common, their effects may be reshaping everyday food choices in ways that extend far beyond individual health. When people in the United States begin using ...

India's obesity drug market is experiencing rapid growth, driven by rising lifestyle diseases and the launch of blockbuster ...

THREE women from one family lost a combined weight of over 20st after turning to fat-busting jabs three years ago – and now they want to help others achieve their dream body. Debbie ...

Wegovy is one of the new wave medications that in recent years have had a huge impact on people looking to l ose weight.

Dems making massive electoral gains, should GOP worry? Sam Mirejovsky | RISING Conservative analyst Sam Mirejovsky joins ...